Dido Vassilacopoulou

Dr. Dido Vassilacopoulou

National and Kapodistrian University of Athens, Athens, Greece

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
MSMaria-Zaharenia Siaterli
Maria-Zaharenia Siaterli
DVDido Vassilacopoulou
Dido Vassilacopoulou
EFEmmanuel G. Fragoulis
Emmanuel G. Fragoulis

1 October 2004 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
DVDido Vassilacopoulou
Dido Vassilacopoulou
DSDiamantis C. Sideris
Diamantis C. Sideris
AVAlice Vassiliou
Alice Vassiliou
EFEmmanuel G. Fragoulis
Emmanuel G. Fragoulis

1 December 2018 in Cells
Verified
Journal Article
Open access
PDF file
EFEfseveia Frakolaki
Efseveia Frakolaki
PKPanagiota Kaimou
Panagiota Kaimou
MMMaria Moraiti
Maria Moraiti
KKKATERINA KALLIAMPAKOU
KATERINA KALLIAMPAKOU
KKKalliopi Karampetsou
Kalliopi Karampetsou
NVNiki Vassilaki
Niki Vassilaki
Low oxygen tension exerts a profound effect on the replication of several DNA and RNA viruses. In vitro propagation of Dengue virus (DENV) has been conventionally studied under atmospheric oxygen levels despite that in vivo, the tissue microenvironment is hypoxic. Here, we compared the efficiency of DENV replication in liver cells, monocytes, and epithelial cells under hypoxic and normoxic conditions, investigated the ability of DENV to induce a hypoxia response and metabolic reprogramming and determined the underlying molecular mechanism. In DENV-infected cells, hypoxia had no effect on virus entry and RNA translation, but enhanced RNA replication. Overexpression and silencing approaches as well as chemical inhibition and energy substrate exchanging experiments showed that hypoxia-mediated enhancement of DENV replication depends on the activation of the key metabolic regulators hypoxia-inducible factors 1α/2α (HIF-1α/2α) and the serine/threonine kinase AKT. Enhanced RNA replication correlates directly with an increase in anaerobic glycolysis producing elevated ATP levels. Additionally, DENV activates HIF and anaerobic glycolysis markers. Finally, reactive oxygen species were shown to contribute, at least in part through HIF, both to the hypoxia-mediated increase of DENV replication and to virus-induced hypoxic reprogramming. These suggest that DENV manipulates hypoxia response and oxygen-dependent metabolic reprogramming for efficient viral replication.

5 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
EFEfseveia Frakolaki
Efseveia Frakolaki
KKKaterina I. Kalliampakou
Katerina I. Kalliampakou
PKPanagiota Kaimou
Panagiota Kaimou
MMMaria Moraiti
Maria Moraiti
NKNikolaos Kolaitis
Nikolaos Kolaitis
NVNiki Vassilaki
Niki Vassilaki
L-dopa decarboxylase (DDC) that catalyzes the biosynthesis of bioactive amines, such as dopamine and serotonin, is expressed in the nervous system and peripheral tissues, including the liver, where its physiological role remains unknown. Recently, we reported a physical and functional interaction of DDC with the major signaling regulator phosphoinosite-3-kinase (PI3K). Here, we provide compelling evidence for the involvement of DDC in viral infections. Studying dengue (DENV) and hepatitis C (HCV) virus infection in hepatocytes and HCV replication in liver samples of infected patients, we observed a negative association between DDC and viral replication. Specifically, replication of both viruses reduced the levels of DDC mRNA and the ~120 kDa SDS-resistant DDC immunoreactive functional complex, concomitant with a PI3K-dependent accumulation of the ~50 kDa DDC monomer. Moreover, viral infection inhibited PI3K-DDC association, while DDC did not colocalize with viral replication sites. DDC overexpression suppressed DENV and HCV RNA replication, while DDC enzymatic inhibition enhanced viral replication and infectivity and affected DENV-induced cell death. Consistently, we observed an inverse correlation between DDC mRNA and HCV RNA levels in liver biopsies from chronically infected patients. These data reveal a novel relationship between DDC and Flaviviridae replication cycle and the role of PI3K in this process.

1 September 2019 in Pathophysiology
Verified
Journal Article
Closed access
ASAikaterina L. Stefi
Aikaterina L. Stefi
LMLukas H. Margaritis
Lukas H. Margaritis
ASAikaterini S. Skouroliakou
Aikaterini S. Skouroliakou
DVDido Vassilacopoulou
Dido Vassilacopoulou

20 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
GMGeorge Pasteur Mpekoulis
George Pasteur Mpekoulis
KKKATERINA KALLIAMPAKOU
KATERINA KALLIAMPAKOU
RMRaphaela S. Milona
Raphaela S. Milona
DLDespoina Lagou
Despoina Lagou
IAIOANNIDIS ANASTASIOS
IOANNIDIS ANASTASIOS
NVNiki Vassilaki
Niki Vassilaki
The SARS-CoV-2 infection was previously associated with the expression of the dopamine biosynthetic enzyme L-Dopa decarboxylase (DDC). Specifically, a negative correlation was detected between DDC mRNA and SARS-CoV-2 RNA levels in in vitro infected epithelial cells and the nasopharyngeal tissue of COVID-19 patients with mild/no symptoms. However, DDC, among other genes related to both DDC expression and SARS-CoV-2-infection (ACE2, dACE2, EPO), was upregulated in these patients, possibly attributed to an orchestrated host antiviral response. Herein, by comparing DDC expression in the nasopharyngeal swab samples of severe/critical to mild COVID-19 cases, we showed a 20 mean-fold reduction, highlighting the importance of the expression of this gene as a potential marker of COVID-19 severity. Moreover, we identified an association of SARS-CoV-2 infection with the expression of key catecholamine biosynthesis/metabolism-related genes, in whole blood samples from hospitalized patients and in cultured cells. Specifically, viral infection downregulated the biosynthetic part of the dopamine pathway (reduction in DDC expression up to 7.5 mean-fold), while enhanced the catabolizing part (increase in monoamine oxidases A and B expression up to 15 and 10 mean-fold, respectively) in vivo, irrespectively of the presence of comorbidities. In accordance, dopamine levels in the sera of severe cases were reduced (up to 3.8 mean-fold). Additionally, a moderate positive correlation between DDC and MAOA mRNA levels (r = 0.527, p < 00001) in the blood was identified upon SARS-CoV-2-infection. These observations were consistent to the gene expression data from SARS-CoV-2-infected Vero E6 and A549 epithelial cells. Furthermore, L-Dopa or dopamine treatment of infected cells attenuated the virus-derived cytopathic effect by 55% and 59%, respectively. The SARS-CoV-2 mediated suppression of dopamine biosynthesis in cell culture was, at least in part, attributed to hypoxia-like conditions triggered by viral infection. These findings suggest that L-Dopa/dopamine intake may have a preventive or therapeutic value for COVID-19 patients.